236 related articles for article (PubMed ID: 28754237)
1. Treatment of larva migrans syndrome with long-term administration of albendazole.
Hombu A; Yoshida A; Kikuchi T; Nagayasu E; Kuroki M; Maruyama H
J Microbiol Immunol Infect; 2019 Feb; 52(1):100-105. PubMed ID: 28754237
[TBL] [Abstract][Full Text] [Related]
2. Albendazole: a new therapeutic regimen in cutaneous larva migrans.
Rizzitelli G; Scarabelli G; Veraldi S
Int J Dermatol; 1997 Sep; 36(9):700-3. PubMed ID: 9352416
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Ascaris suum-specific antibodies in Austrian patients with suspected larva migrans visceralis (VLM) syndrome.
Schneider R; Auer H
Parasitol Res; 2016 Mar; 115(3):1213-9. PubMed ID: 26637313
[TBL] [Abstract][Full Text] [Related]
4. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection.
Leonardi D; Echenique C; Lamas MC; Salomon CJ
J Antimicrob Chemother; 2009 Aug; 64(2):375-8. PubMed ID: 19497941
[TBL] [Abstract][Full Text] [Related]
5. One-week therapy with oral albendazole in hookworm-related cutaneous larva migrans: a retrospective study on 78 patients.
Veraldi S; Bottini S; Rizzitelli G; Persico MC
J Dermatolog Treat; 2012 Jun; 23(3):189-91. PubMed ID: 21294643
[TBL] [Abstract][Full Text] [Related]
6. Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009.
Pinelli E; Herremans T; Harms MG; Hoek D; Kortbeek LM
Eur J Clin Microbiol Infect Dis; 2011 Jul; 30(7):873-9. PubMed ID: 21365288
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous larva migrans with albendazole. Preliminary report.
Torres JR; Orihuela AR; Garcia D; Abdul-Hadi S
Rev Inst Med Trop Sao Paulo; 1989; 31(1):56-8. PubMed ID: 2814206
[TBL] [Abstract][Full Text] [Related]
8. [Visceral and ocular Larva migrans: epidemiologic study, clinical and immunologic findings on 20 cases, adult and child].
Scaglia M; Gatti S; Bruno A; Cevini C; Chichino G; Magnani B; Brustia R
Bull Soc Pathol Exot Filiales; 1989; 82(3):410-21. PubMed ID: 2766448
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous larva migrans in Turkey: an imported case report].
Sönmezer MÇ; Erdinç Ş; Tülek N; Babür C; Büyükdemirci A; İlgar T; Ertem G
Mikrobiyol Bul; 2017 Jan; 51(1):94-99. PubMed ID: 28283015
[TBL] [Abstract][Full Text] [Related]
10. Development of nested multiplex polymerase chain reaction (PCR) assay for the detection of Toxocara canis, Toxocara cati and Ascaris suum contamination in meat and organ meats.
Wang Z; Shibata M; Nguyen YTH; Hayata Y; Nonaka N; Maruyama H; Yoshida A
Parasitol Int; 2018 Oct; 67(5):622-626. PubMed ID: 29920343
[TBL] [Abstract][Full Text] [Related]
11. Atypical
Huynh TM; Tran KQL; Dinh TH; Vo MM; Pham TQ; Vo TD
Korean J Gastroenterol; 2024 Jun; 83(6):247-252. PubMed ID: 38918038
[TBL] [Abstract][Full Text] [Related]
12. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial.
Stürchler D; Schubarth P; Gualzata M; Gottstein B; Oettli A
Ann Trop Med Parasitol; 1989 Oct; 83(5):473-8. PubMed ID: 2694978
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a new therapeutic regimen with albendazole in cutaneous larva migrans.
Veraldi S; Rizzitelli G
Eur J Dermatol; 1999; 9(5):352-3. PubMed ID: 10417435
[TBL] [Abstract][Full Text] [Related]
14. Two imported cases of cutaneous larva migrans.
Park JW; Kwon SJ; Ryu JS; Hong EK; Lee JU; Yu HJ; Ahn MH; Min DY
Korean J Parasitol; 2001 Mar; 39(1):77-81. PubMed ID: 11301593
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of the cutaneous larva migrans syndrome "Larbish" with albendazole. Apropos of 18 cases].
Coulaud JP; Binet D; Voyer C; Samson C; Moreau G; Rossignol JF
Bull Soc Pathol Exot Filiales; 1982 Nov; 75(5):534-7. PubMed ID: 7165902
[No Abstract] [Full Text] [Related]
16. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans.
Caumes E; Carriere J; Datry A; Gaxotte P; Danis M; Gentilini M
Am J Trop Med Hyg; 1993 Nov; 49(5):641-4. PubMed ID: 8250105
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of albendazole ointment on cutaneous larva migrans in a 2 years child.
Alarcon-Soldevilla F; Gonzalez-Valverde FM; Alonso-Osmer EC; López-Ávila Á
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Apr; 37(4):281-282. PubMed ID: 29907365
[No Abstract] [Full Text] [Related]
18. Myocarditis associated with visceral larva migrans due to Toxocara canis.
Abe K; Shimokawa H; Kubota T; Nawa Y; Takeshita A
Intern Med; 2002 Sep; 41(9):706-8. PubMed ID: 12322796
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous larva migrans: 34 outside cases].
Puente Puente S; Bru Gorraiz F; Azuara Solís M; Colomo Gómez C; González Lahoz JM
Rev Clin Esp; 2004 Dec; 204(12):636-9. PubMed ID: 15710070
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal myelitis caused by visceral larva migrans associated with Toxocara cati infection: case report.
Fukae J; Kawanabe T; Akao N; Kado M; Tokoro M; Yokoyama K; Hattori N
Clin Neurol Neurosurg; 2012 Sep; 114(7):1091-4. PubMed ID: 22424728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
